Morgan Stanley downgraded Daicel (DACHF) to Equal Weight from Overweight with a price target of 1,400 yen, down from 2,300 yen. The firm expects the fiscal year to start with Q1 profits falling 26% on an unanticipated hit from the moving average for raw material costs, the analyst tells investors.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DACHF:
- Daicel Corporation Corrects Financial Results for FY 2025
- Daicel Corporation Corrects Financial Results for FY 2024
- Daicel Corporation Proposes Amendments to Enhance Business Alignment and Management Flexibility
- Daicel Corporation Announces Cancellation of 10 Million Treasury Shares
- Daicel Corporation Reports Increased Sales but Declining Profits for FY2025